Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 68

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 68
---
 from the later of the date on which the Purchaser received the Superior Proposal Notice and the date on which the Purchaser received all of the material specified in Section 6.2(b)(iv)(B) with respect to such new Superior Proposal from the 
 Company.                                                                                                                                                                                                                                        |

| (e) | The Board shall promptly reaffirm the Board Recommendation by press release after any Acquisition Proposal                                                                                                                                             
 which is not determined to be a Superior Proposal is publicly announced or publicly disclosed or the Board determines that a proposed amendment to the terms of this Agreement or the Plan of Arrangement as contemplated under Section 6.2(c) would   
 result in an Acquisition Proposal no longer being a Superior Proposal. The Company shall provide the Purchaser and its outside legal counsel with a reasonable opportunity to review the form and content of any such press release and shall make all 
 reasonable amendments to such press release as requested by the Purchaser and its outside legal counsel.                                                                                                                                               |

| (f) | If the Meeting is to be held during a Right to Match Period, the Company may, and shall at the request of the                                                                                                                            
 Purchaser, postpone or adjourn the Meeting to a date that is not more than fifteen (15) days after the scheduled date of the Meeting, but in any event to a date that is not less than five (5) Business Days prior to the Outside Date. |

| (g) | Except as provided under Section 6.2(f), nothing contained in this Section 6.2 shall limit in any way                                                 
 the obligation of the Company to convene and hold the Meeting in accordance with Section 2.5 of this Agreement while this Agreement remains in force. |

| (h) | Nothing in this Agreement shall prevent the Board of Directors or the Company from responding through a                                                                                                                                                   
 directors’ circular or otherwise as required by applicable Laws to an Acquisition Proposal where such response is not an acceptance, approval, endorsement or recommendation of such Acquisition Proposal and does not otherwise constitute a             
 Change of Recommendation; provided, that the Company shall provide the Purchaser and its outside legal counsel with a reasonable opportunity to review the form and content of such circular or other disclosure and shall make all reasonable amendments 
 to such circular or other disclosure as requested by the Purchaser and its outside legal counsel.                                                                                                                                                         |

| (i) | Notwithstanding the foregoing, nothing in Section 6.1 and this Section 6.2 shall require the sharing                                                                                                                                                     
 with the Purchaser of any information considered by external legal counsel of